Halozyme Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence.
HALO Key Statistics
Stock Snapshot
As of today, Halozyme Therapeutics(HALO) shares are valued at $70.26. The company's market cap stands at 8.26B, with a P/E ratio of 14.74.
On 2025-11-12, Halozyme Therapeutics(HALO) stock traded between a low of $69.54 and a high of $71.80. Shares are currently priced at $70.26, which is +1.0% above the low and -2.1% below the high.
Halozyme Therapeutics(HALO) shares are trading with a volume of 965.48K, against a daily average of 2.97M.
In the last year, Halozyme Therapeutics(HALO) shares hit a 52-week high of $79.50 and a 52-week low of $42.01.
In the last year, Halozyme Therapeutics(HALO) shares hit a 52-week high of $79.50 and a 52-week low of $42.01.
HALO News
In early November 2025, Halozyme Therapeutics reported strong third-quarter results with year-to-date revenue of US$944.84 million and net income of US$458.48 m...
Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI Analyst can help you make smarter investment...